ASAH2B

Model summary

A soluble human enzyme that hydrolyzes ceramide at neutral to alkaline pH to generate sphingosine and free fatty acids, thereby tuning sphingolipid signaling pathways that govern apoptosis and differentiation. A substantial cytosolic pool performs neutral ceramidase chemistry, while a nucleoplasmic fraction associates with chromatin and spliceosomal assemblies to modulate pre-mRNA splicing. Its mechanism centers on a conserved ceramidase catalytic core supported by protein-binding interfaces that enable oligomerization and assembly with RNA-processing machinery, coupling metabolic cues to nuclear RNA processing.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   Three concordant signatures define a neutral/alkaline non-lysosomal ceramidase core that occupies the C-terminal two-thirds of the protein: IPR006823 (Neutral/alkaline nonlysosomal ceramidase, family) spans residues 26–163; within it, IPR031331 (Neutral/alkaline non-lysosomal ceramidase, C-terminal domain) extends from residues 29–162; and this is encompassed by IPR038445 (Neutral ceramidase, C-terminal domain superfamily) from residues 29–165. The tight clustering of ceramidase-family and C-terminal-domain signatures indicates a conserved catalytic scaffold that hydrolyzes the amide bond of N-acylsphingosines at neutral to alkaline pH. The absence of additional catalytic modules and the dominance of a single enzymatic core argue that the primary molecular function is hydrolysis of ceramides to sphingosine and fatty acids. Such enzymes often rely on oligomerization and adaptor contacts, which rationalizes a capacity for protein binding (GO:0005515) as an auxiliary function that stabilizes complexes and targets the enzyme to specific cellular locales.

2. 02

   From this enzymatic foundation, I infer the biological role.

   Ceramide turnover directly feeds into sphingolipid signaling pathways that govern apoptosis, differentiation, and stress responses. The explicit catalytic architecture that produces sphingosine positions the protein as a regulator of sphingolipid flux rather than a bulk catabolic enzyme. A second axis of evidence arises from cellular localization and nuclear coupling: the protein is detected in the cytosol and nucleoplasm and associates with chromatin. This spatial coupling provides a mechanistic route to influence pre-mRNA processing. Specifically, the nucleoplasmic pool can physically engage spliceosomal assemblies and RNA-processing hubs, aligning with mRNA splicing via the spliceosome (GO:0000398). Thus, the ceramidase architecture supplies the metabolic input, while nucleoplasmic residency and protein-binding capacity provide the conduit to modulate splicing.

3. 03

   Cellular location follows directly from the dual architecture and binding behavior.

   The ceramidase core lacks transmembrane segments and secretion signals, favoring a soluble intracellular enzyme. Its soluble pool is partitioned between the cytosol (GO:0005829) and nucleoplasm (GO:0005654), consistent with a model in which cytosolic ceramide hydrolysis is coordinated with nuclear events. Chromatin association further refines the nucleoplasmic localization and suggests transient residence at transcription-splicing interfaces.

4. 04

   These lines of evidence converge on a mechanistic hypothesis.

   The ceramidase domain hydrolyzes ceramide in the cytosol, tuning the local balance of sphingolipids that signal to apoptosis and differentiation pathways. A fraction of the enzyme traffics to the nucleoplasm, where its protein-binding surfaces assemble with spliceosomal factors and chromatin-bound RNA-processing machinery. Through this, it couples metabolic state to pre-mRNA splicing decisions. Likely interaction partners include spliceosome components (e.g., U2AF and SF3 complexes), serine/arginine-rich splicing regulators, and chromatin-associated adaptors that tether the enzyme to RNA-processing sites. This dual localization and binding propensity explain both enzymatic sphingolipid control and a modulatory role in nuclear RNA splicing.